543 related articles for article (PubMed ID: 19729090)
1. Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis.
Kaur D; Guerin ME; Skovierová H; Brennan PJ; Jackson M
Adv Appl Microbiol; 2009; 69():23-78. PubMed ID: 19729090
[TBL] [Abstract][Full Text] [Related]
2. Assembly of the Mycobacterial Cell Wall.
Jankute M; Cox JA; Harrison J; Besra GS
Annu Rev Microbiol; 2015; 69():405-23. PubMed ID: 26488279
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.
Abrahams KA; Besra GS
Parasitology; 2018 Feb; 145(2):116-133. PubMed ID: 27976597
[TBL] [Abstract][Full Text] [Related]
4. Targeting the formation of the cell wall core of M. tuberculosis.
Barry CE; Crick DC; McNeil MR
Infect Disord Drug Targets; 2007 Jun; 7(2):182-202. PubMed ID: 17970228
[TBL] [Abstract][Full Text] [Related]
5. Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets.
Jankute M; Grover S; Rana AK; Besra GS
Future Microbiol; 2012 Jan; 7(1):129-47. PubMed ID: 22191451
[TBL] [Abstract][Full Text] [Related]
6. The cell envelope glycoconjugates of Mycobacterium tuberculosis.
Angala SK; Belardinelli JM; Huc-Claustre E; Wheat WH; Jackson M
Crit Rev Biochem Mol Biol; 2014; 49(5):361-99. PubMed ID: 24915502
[TBL] [Abstract][Full Text] [Related]
7. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.
Brennan PJ
Tuberculosis (Edinb); 2003; 83(1-3):91-7. PubMed ID: 12758196
[TBL] [Abstract][Full Text] [Related]
8. Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.
Jackson M; McNeil MR; Brennan PJ
Future Microbiol; 2013 Jul; 8(7):855-75. PubMed ID: 23841633
[TBL] [Abstract][Full Text] [Related]
9. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
Xu W; DeJesus MA; Rücker N; Engelhart CA; Wright MG; Healy C; Lin K; Wang R; Park SW; Ioerger TR; Schnappinger D; Ehrt S
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893793
[TBL] [Abstract][Full Text] [Related]
10. The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery.
Brennan PJ; Crick DC
Curr Top Med Chem; 2007; 7(5):475-88. PubMed ID: 17346193
[TBL] [Abstract][Full Text] [Related]
11. A piperidinol-containing molecule is active against
Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
[No Abstract] [Full Text] [Related]
12. Glycoconjugates, hypothetical proteins, and post-translational modification: Importance in host-pathogen interaction and antitubercular intervention development.
Arega AM; Mahapatra RK
Chem Biol Drug Des; 2021 Jul; 98(1):30-48. PubMed ID: 33838076
[TBL] [Abstract][Full Text] [Related]
13. The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.
Alderwick LJ; Harrison J; Lloyd GS; Birch HL
Cold Spring Harb Perspect Med; 2015 Mar; 5(8):a021113. PubMed ID: 25818664
[TBL] [Abstract][Full Text] [Related]
14. Mycobacteriophage Ms6 LysB specifically targets the outer membrane of Mycobacterium smegmatis.
Gil F; Grzegorzewicz AE; Catalão MJ; Vital J; McNeil MR; Pimentel M
Microbiology (Reading); 2010 May; 156(Pt 5):1497-1504. PubMed ID: 20093291
[TBL] [Abstract][Full Text] [Related]
15. Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets.
Alderwick LJ; Birch HL; Mishra AK; Eggeling L; Besra GS
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1325-8. PubMed ID: 17956343
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis.
Puech V; Guilhot C; Perez E; Tropis M; Armitige LY; Gicquel B; Daffé M
Mol Microbiol; 2002 May; 44(4):1109-22. PubMed ID: 12010501
[TBL] [Abstract][Full Text] [Related]
17. Structure, function and biogenesis of the mycobacterial cell wall.
Brennan PJ; Besra GS
Biochem Soc Trans; 1997 Feb; 25(1):188-94. PubMed ID: 9056869
[No Abstract] [Full Text] [Related]
18. An approach for the rational design of new antituberculosis agents.
Pasqualoto KF; Ferreira EI
Curr Drug Targets; 2001 Dec; 2(4):427-37. PubMed ID: 11732641
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis.
Crick DC; Mahapatra S; Brennan PJ
Glycobiology; 2001 Sep; 11(9):107R-118R. PubMed ID: 11555614
[TBL] [Abstract][Full Text] [Related]
20. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.
North EJ; Jackson M; Lee RE
Curr Pharm Des; 2014; 20(27):4357-78. PubMed ID: 24245756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
